|
1
|
Ogura K, Higashi T and Kawai A: Statistics
of soft-tissue sarcoma in Japan: Report from the bone and soft
tissue tumor registry in Japan. J Orthop Sci. 22:755–764. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pisters PW, O'Sullivan B and Maki RG:
Evidence-based recommendations for local therapy for soft tissue
sarcomas. J Clin Oncol. 25:1003–1008. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vlenterie M, Litière S, Rizzo E, Marréaud
S, Judson I, Gelderblom H, Le Cesne A, Wardelmann E, Messiou C,
Gronchi A and van der Graaf WT: Outcome of chemotherapy in advanced
synovial sarcoma patients: Review of 15 clinical trials from the
European organisation for research and treatment of cancer soft
tissue and bone sarcoma group; setting a new landmark for studies
in this entity. Eur J Cancer. 58:62–72. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Palmerini E, Staals EL, Alberghini M,
Zanella L, Ferrari C, Benassi MS, Picci P, Mercuri M, Bacci G and
Ferrari S: Synovial sarcoma: Retrospective analysis of 250 patients
treated at a single institution. Cancer. 115:2988–2998. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ferrari A, Gronchi A, Casanova M, Meazza
C, Gandola L, Collini P, Lozza L, Bertulli R, Olmi P and Casali PG:
Synovial sarcoma: A retrospective analysis of 271 patients of all
ages treated at a single institution. Cancer. 101:627–634. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eilber FC, Brennan MF, Eilber FR, Eckardt
JJ, Grobmyer SR, Riedel E, Forscher C, Maki RG and Singer S:
Chemotherapy is associated with improved survival in adult patients
with primary extremity synovial sarcoma. Ann Surg. 246:105–113.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Canter RJ, Qin LX, Maki RG, Brennan MF,
Ladanyi M and Singer S: A synovial sarcoma-specific preoperative
nomogram supports a survival benefit to ifosfamide-based
chemotherapy and improves risk stratification for patients. Clin
Cancer Res. 14:8191–8197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lewis JJ, Antonescu CR, Leung DH, Blumberg
D, Healey JH, Woodruff JM and Brennan MF: Synovial sarcoma: A
multivariate analysis of prognostic factors in 112 patients with
primary localized tumors of the extremity. J Clin Oncol.
18:2087–2094. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Trassard M, Le Doussal V, Hacène K,
Terrier P, Ranchère D, Guillou L, Fiche M, Collin F, Vilain MO,
Bertrand G, et al: Prognostic factors in localized primary synovial
sarcoma: A multicenter study of 128 adult patients. J Clin Oncol.
19:525–534. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Italiano A, Penel N, Robin YM, Bui B, Le
Cesne A, Piperno-Neumann S, Tubiana-Hulin M, Bompas E, Chevreau C,
Isambert N, et al: Neo/adjuvant chemotherapy does not improve
outcome in resected primary synovial sarcoma: A study of the French
sarcoma group. Ann Oncol. 20:425–430. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Amin M, Edge S, Greene F, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC Cancer Staging Manual (8th edition). (New
York). Springer. 2017.
|
|
12
|
Trojani M, Contesso G, Coindre JM, Rouesse
J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F and
Lagarde C: Soft-tissue sarcomas of adults; study of pathological
prognostic variables and definition of a histopathological grading
system. Int J Cancer. 33:37–42. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krieg AH, Hefti F, Speth BM, Jundt G,
Guillou L, Exner UG, von Hochstetter AR, Cserhati MD, Fuchs B,
Mouhsine E, et al: Synovial sarcomas usually metastasize after
>5 years: A multicenter retrospective analysis with minimum
follow-up of 10 years for survivors. Ann Oncol. 22:458–467. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bergh P, Meis-Kindblom JM, Gherlinzoni F,
Berlin O, Bacchini P, Bertoni F, Gunterberg B and Kindblom LG:
Synovial sarcoma: Identification of low and high risk groups.
Cancer. 85:2596–2607. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vlenterie M, Ho VK, Kaal SE, Vlenterie R,
Haas R and van der Graaf WT: Age as an independent prognostic
factor for survival of localised synovial sarcoma patients. Br J
Cancer. 113:1602–1606. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Yang Y, Wang C and Shi Y: Adjuvant
chemotherapy decreases and postpones distant metastasis in
extremity stage IIB/III synovial sarcoma patients. J Surg Oncol.
106:162–168. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vining CC, Sinnamon AJ, Ecker BL, Kelz RR,
Fraker DL, Roses RE and Karakousis GC: Adjuvant chemotherapy in
resectable synovial sarcoma. J Surg Oncol. 116:550–558. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song S, Park J, Kim HJ, Kim IH, Han I, Kim
HS and Kim S: Effects of adjuvant radiotherapy in patients with
synovial sarcoma. Am J Clin Oncol. 40:306–311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Naing KW, Monjazeb AM, Li CS, Lee LY, Yang
A, Borys D and Canter RJ: Perioperative radiotherapy is associated
with improved survival among patients with synovial sarcoma: A SEER
analysis. J Surg Oncol. 111:158–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
